Neoadjuvant immunotherapystereotactic body radiation therapySBRTcemiplimabBRANY IRBHCC
… ~55% disease-free survival (DFS) at 2 years with surveillance. Neoadjuvant immunotherapy induces tumor necrosis and may reduce the risk of local and dis…
7,227articles mentioning treatments
16,644treatment mentions
4,719distinct treatments extracted
0%of mentions human-reviewed
All extracted treatments
Showing 1–60 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
Immunotherapy241Chemotherapy205EVT77Surgery74Radiotherapy69Treatment65Mechanical thrombectomy64Antiretroviral therapy57Anticoagulation56ART51Endovascular treatment51Immunosuppressive therapy39Pharmacotherapy38Pulmonary Rehabilitation38PrEP33Liver Transplantation33Middle meningeal artery embolization31Palliative care30Physiotherapy30Intravenous thrombolysis29Endovascular Thrombectomy29Cancer treatment28Mechanical ventilation28Endovascular therapy27Acupuncture26Physical therapy26TAVI25Endovascular embolization25Surgical resection25Dual antiplatelet therapy25Cardiac Rehabilitation24Regional anesthesia24Immunosuppression24Cognitive behavioural therapy24MMAE23Venous sinus stenting23Conservative management23Plasma exchange23Corticosteroid therapy23Thrombectomy22Medical therapy22Neoadjuvant chemotherapy22Catheter Ablation22Percutaneous Coronary Intervention22Statin therapy21Antiplatelet therapy21antibiotics21Targeted therapies21CPAP20Regional anaesthesia20Oxygen therapy20General Anaesthesia20Immunotherapies20DAPT19Dialysis19Combination therapy19anti-PD-1 therapy19Antibiotic therapy19Surgical intervention19adjuvant chemotherapy19
Articles mentioning treatments
7,227 articles · page 58 of 603Immunotherapycancers
…Background Immunotherapy has become an essential therapeutic strategy in the treatment o…
immunotherapyanti-PD-1 therapyWest China Hospital of Sichuan UniversityInstitutional Review BoardCRCAkkClinicalTrials.govMSS CRC
…s with higher Akk abundance showed better clinical responses to immunotherapy. The phase I trial (N=20) demonstrated favorable safety: 70% (1…
immunotherapyanti-PD-1 therapyWest China Hospital of Sichuan UniversityAkkInstitutional Review BoardCRCClinicalTrials.govMSS CRC
…s with higher Akk abundance showed better clinical responses to immunotherapy. The phase I trial (N = 22) demonstrated favorable safety: 86% …
anti-PD-1 therapynivolumabRP1Vusolimogene oderparepvecmelanoma
…0-mutant melanoma as first-line therapy or after progression on anti-PD-1 therapy. However, prior treatment with BRAF-directed therapy can dimini…
chemotherapyLung cancerbevacizumabPD-1 inhibitoradvanced driver gene-negative nsNSCLC
… gene-negative nsNSCLC patients, first-line PD-1 inhibitor plus chemotherapy demonstrated significantly improved PFS compared to bevacizumab…
chemotherapyimmuno-chemotherapyimmune checkpoint inhibitorsClinicalTrials.govZhongda Hospital Affiliated to Southeast UniversityBTCadvanced biliary tract cancer
… has been updated to immune checkpoint inhibitors combined with chemotherapy. However, immuno-chemotherapy for BTC still demonstrates signif…
T-FUSUniversity of Virginia[89Zr]-αCD47[89Zr]-aCD47breast cancersolid tumorsNIH DP5OD031846breast tumors[18F]-Fludeoxyglucose
… 2 and 5 post-treatment using a Philips EPIQ scanner. Following T-FUS, mice received intravenous (i.v.) injection of [18F]-Fludeoxygl…
surgerymelanomaBrown University HealthipilimumabnivolumabBrain metastasesadvanced melanomaLifespan- Rhode Island Hospital Institutional Review BoardICI
… ICI with surgery may improve survival in MBM patients. Upfront surgery was associated with longer progression-free survival but not ov…
immunotherapynon-small cell lung cancerpancreatic ductal adenocarcinoma
…, Ribas A. Primary, adaptive, and acquired resistance to cancer immunotherapy. Cell. 2017;168:707–723.Chowell D, Yoo S-K, Valero C, Pastore A…
chemotherapyimmunotherapyPancreatic ductal adenocarcinoma (PDAC)gemcitabine
… higher MPO activity in circulating neutrophils correlated with chemotherapy resistance.Conclusions Overall, our study demonstrates the crit…
chemotherapyFOLFIRINOXPancreatic cancerWest Virginia Universitygemcitabinegemcitabine-based
…ered in pancreatic disease, especially after treatments such as chemotherapy. The goal of this study is to characterize monocyte subsets in …